Why the study?
Is Adenovirus 36 seropositivity associated with obesity and diabetes in an Arab population?
Is Adenovirus 36 seropositivity associated with obesity and diabetes in an Arab population?
In a UAE population, Adenovirus 36 infection is highly prevalent but is not associated with obesity or diabetes status, challenging previous associations.
Answers are grounded in this paper and cite their sources.
Adv36 seropositivity was unassociated with obesity or diabetes in UAE adults; leaves open ethnic generalizability of prior associations.
Prior infection with adenovirus 36 (Adv36) has been associated with increased adiposity, improved insulin sensitivity, and a lower prevalence of diabetes. This study investigated the prevalence of Adv36 seropositivity and its association with obesity and diabetes among adults attending a diabetes centre in the UAE.Participants (N = 973) with different weight and glucose tolerance categories were recruited. Adv36 seropositivity (Adv36 + ) was assessed using ELISA. Differences among groups were analyzed using statistical tests as appropriate to the data. Prevalence of Adv36+ in the study population was 47%, with no significant difference in obese and non-obese subgroups (42.5% vs 49.6% respectively; p=non-significant). Females were more likely to be Adv36+ compared to males (odds ratio 1.78; 95% CI 1.36-2.32, p < 0.001). We found no significant association between Adv36 seropositivity and different BMI categories, or glucose tolerance status. In our population, the effect of Adv36 infection on lipid profile varied between healthy individuals and individuals with obesity. Adv36 infection is more prevalent in the UAE than in other countries but has no association with obesity. Our study found that females were more likely to be Adv36 positive regardless of weight or diabetes status.
No takes yet. Share an insight, caveat, or question.
Lessan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: